Home › Cancer (all types) › NCT03977402
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
INST UNM 1521: Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * 18 years of age and older. * Has a diagnosis of cancer or is suspected of having cancer. * Able to understand and sign the Informed Consent form directly. * Pregnant women are permitted to be enrolled. Exclusion Criteria: * Prisoners
About the study
The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.
What is being tested
- Biological specimen collection (other)
Sponsor: New Mexico Cancer Research Alliance · Participants: 47,500 · Started: Jan 27, 2016
Contact the study team
- Christine Serway, PhD · Phone: 505-272-2412
Official record on ClinicalTrials.gov — NCT03977402
Locations in the U.S.
| New Mexico | University of New Mexico Comprehensive Cancer Center, Albuquerque |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.